EFFECT OF A CO-STIMULATORY ENDODOMAIN ON THE PERFORMANCE OF T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AT CD19 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES

被引：1
|
作者：
Ramos, C. A. [1 ]
Savoldo, B. [1 ]
Liu, E. [1 ]
Bollard, C. M. [1 ]
Carrum, G. [1 ]
Kamble, R. T. [1 ]
Mims, M. P. [1 ]
Keating, M. [2 ]
Gee, A. P. [1 ]
Mei, Z. [1 ]
Rooney, C. M. [1 ]
Heslop, H. E. [1 ]
Brenner, M. K. [1 ]
Dotti, G. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.186
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
163
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [41] Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
    Schuster, Stephen J.
    Svoboda, Jakub
    Chong, Elise A.
    Nasta, Sunita D.
    Mato, Anthony R.
    Anak, Ozlem
    Brogdon, Jennifer L.
    Pruteanu-Malinici, Iulian
    Bhoj, Vijay
    Landsburg, Daniel
    Wasik, Mariusz
    Levine, Bruce L.
    Lacey, Simon F.
    Melenhorst, Jan J.
    Porter, David L.
    June, Carl H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2545 - 2554
  • [42] Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy with Dual Targeting of CD19 and CD70 to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Tu, Sanfang
    Zhou, Lijuan
    Huang, Rui
    Zhou, Xuan
    Yang, Jilong
    Li, Meifang
    Jin, Bo
    Wang, Langqi
    Zhuo, Yaqi
    Chen, Huifang
    Chang, Lung-Ji
    Li, Yuhua
    BLOOD, 2023, 142
  • [43] Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
    Fang Bao
    Wei Wan
    Ting He
    Feifei Qi
    Guanghua Liu
    Kai Hu
    Xin-an Lu
    Ping Yang
    Fei Dong
    Jing Wang
    Hongmei Jing
    Cancer Gene Therapy, 2019, 26 : 248 - 255
  • [44] Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
    Bao, Fang
    Wan, Wei
    He, Ting
    Qi, Feifei
    Liu, Guanghua
    Hu, Kai
    Lu, Xin-an
    Yang, Ping
    Dong, Fei
    Wang, Jing
    Jing, Hongmei
    CANCER GENE THERAPY, 2019, 26 (7-8) : 248 - 255
  • [45] Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/ refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Jacoby, Elad
    Toren, Amos
    Shouval, Roni
    Itzhaki, Orit
    Avigdor, Abraham
    Shimoni, Avichai
    Nagler, Arnon
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2024, 72 (04)
  • [46] The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: a meta-analysis
    Zhou, Hui
    Luo, Yuling
    Zhu, Sha
    Wang, Xi
    Zhao, Yunuo
    Ou, Xuejin
    Zhang, Tao
    Ma, Xuelei
    BMC CANCER, 2018, 18
  • [47] The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis
    Hui Zhou
    Yuling Luo
    Sha Zhu
    Xi Wang
    Yunuo Zhao
    Xuejin Ou
    Tao Zhang
    Xuelei Ma
    BMC Cancer, 18
  • [48] Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)-expressing T cells
    Mikhailova, Ekaterina
    Illarionova, Olga
    Shelikhova, Larisa
    Zerkalenkova, Elena
    Molostova, Olga
    Olshanskaya, Yulia
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    Popov, Alexander
    HAEMATOLOGICA, 2022, 107 (04) : 970 - 974
  • [49] Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
    Kochenderfer, James N.
    Dudley, Mark E.
    Kassim, Sadik H.
    Somerville, Robert P. T.
    Carpenter, Robert O.
    Stetler-Stevenson, Maryalice
    Yang, James C.
    Phan, Giao Q.
    Hughes, Marybeth S.
    Sherry, Richard M.
    Raffeld, Mark
    Feldman, Steven
    Lu, Lily
    Li, Yong F.
    Ngo, Lien T.
    Goy, Andre
    Feldman, Tatyana
    Spaner, David E.
    Wang, Michael L.
    Chen, Clara C.
    Kranick, Sarah M.
    Nath, Avindra
    Nathan, Debbie-Ann N.
    Morton, Kathleen E.
    Toomey, Mary Ann
    Rosenberg, Steven A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) : 540 - U31
  • [50] How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?
    de Ramon Ortiz, Carmen
    Wang, Sisi
    Stathis, Anastasios
    Bertoni, Francesco
    Zenz, Thorsten
    Novak, Urban
    Simonetta, Federico
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
12345